Condition: Acute Myocardial Infarction · Sponsor: Dong-A University
DAPT de-escalation strategies to reduce bleeding include de-escalation of DAPT intensity (downgrading from potent P2Y12 inhibitor at conventional doses to either clopidogrel or reduced-dose prasugrel) or abbreviation of DAPT duration. The EASTYLE trial will evaluate a hybrid DAPT de-escalation strategy (reduced-dose ticagrelor, followed by aspirin early discontinuation) in AMI patients, compared with a conventional DAPT strategy.
This description comes directly from the study's public registry record.
Moo Hyun Kim, MD, PhD · +82-51-240-2976 · kimmh@dau.ac.kr
Young-Hoon Jeong, MD, PhD · +82-2-2610-6795 · goodoctor@naver.com
Always discuss trial participation with your own doctor first.
| DongA University Hospital | Busan, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04755387